Gamma Medica offers LumaGEM® MBI System, an FDA-cleared dual-headed digital imaging system.
Gamma Medica, Inc. is proud to offer the LumaGEM® MBI System. As the first commercially available, FDA cleared, planar, dual head, fully solid state digital imaging system utilizing cadmium zinc telluride (CZT) technology used for breast imaging, LumaGEM is able to detect millimeter-size breast cancers missed by mammography, especially in women with dense breast tissue.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 22, 2014 | Series B | $11.50M | 1 | Hercules Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hercules Capital | Yes | Series B |